Arcadia Biosciences Inc (NAS:RKDA)
$ 4.24 0.19 (4.69%) Market Cap: 5.78 Mil Enterprise Value: -2.01 Mil PE Ratio: 0 PB Ratio: 0.49 GF Score: 66/100

Q1 2019 Arcadia Biosciences Inc Earnings Call Transcript

May 08, 2019 / 08:30PM GMT
Release Date Price: $236 (+3.33%)
Operator;Rajendra Ketkar
Arcadia Biosciences, Inc. - President, CEO &amp

Good afternoon, and welcome to the Arcadia Bioscience (sic) [Arcadia Biosciences] First Quarter 2019 Earnings Conference Call. Today's presenters will be Raj Ketkar, President and CEO; and Matt Plavan, CFO and President of Arcadia Special Genomics (sic) [Arcadia Specialty Genomics].

This call is being webcast, and you can refer to the company's press release on slides at arcadiabio.com.

Before we start, if you refer to Slide 2, we'd like to remind you that Arcadia Biosciences will be making forward-looking statements on the call based on current expectations and current available information. However, since these statements are based on facts and involve risk and uncertainties, the company's actual performance and results may differ manually from the -- those discussed and implied today. If you review the company's safe harbor language in those most certain filed 10-K and again, on Slide 2 of the presentation.

With that, I will now turn the call over to Raj Ketkar, President and CEO.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot